Prelude Therapeutics (PRLD) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Prelude Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $25.0M and 0 sold $0 of PRLD stock on the open market.
Get emailed when insiders cluster-buy stocks like PRLD
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PRLD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $25.0M | 4 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Prelude Therapeutics Inc insiders reported open-market purchases totaling $25.0M, while 0 insiders reported sales totaling $0.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 23SEC | Orbimed Genesis Gp LlcDirector | Buy | 1,689,18911,808,945 held (+17%) | $4.44 | $7.5M | -12.4% | — |
| Apr 23SEC | David P BonitaDirector | Buy | 1,689,18911,808,945 held (+17%) | $4.44 | $7.5M | -12.4% | — |
| Apr 23SEC | Orbimed Genesis Gp LlcDirector | Buy | 1,126,126new position | $4.44 | $5.0M | -12.4% | — |
| Apr 23SEC | David P BonitaDirector | Buy | 1,126,126new position | $4.44 | $5.0M | -12.4% | — |
Insiders at Prelude Therapeutics Inc
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Orbimed Genesis Gp LlcDirector | $12.5M | — | Apr 23, 2026 | — |
| David P BonitaDirector | $12.5M | — | Apr 23, 2026 | — |
PRLD stock: common questions
Are Prelude Therapeutics Inc insiders buying PRLD stock?
In the past 12 months, 2 insiders reported open-market purchases of PRLD worth $25.0M. The latest was Director Orbimed Genesis Gp Llc bought $7.5M of PRLD at $4.44 — first open-market purchase in our records.
Are Prelude Therapeutics Inc insiders selling PRLD stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PRLD's 52-week range?
Over the past year PRLD has traded between $1.19 and $6.63. It last closed at $3.89 on Oct 9, 2026.